CTLA-4lg in combination with anti-CD40L prolongs xenograft survival and inhibits anti-Gal Ab production in GT-Ko mice

American Journal of Transplantation

Volumn 2, Issue 1, 2002, Pages 41-47

  Yin, Dengping ^a   Ma, Lianli ^a   Shen, Jikun ^a   Byrne, Guerard W ^b   Logan, John S ^b   Chong, Anita S F ^a  

^a RUSH UNIVERSITY MEDICAL CENTER   (United States)

^b Nextran   (United States)

Author keywords

Anti CD40L; Anti Gal antibodies; CTLA 4lg; Galactosyltransferase knock out; Humoral responses; Mice; Transplantation; Xenoantibodies; Xenotransplant

Indexed keywords

ALPHA 1,3 GALACTOSYLTRANSFERASE ANTIBODY; ANTIBODY; CD40 LIGAND MONOCLONAL ANTIBODY; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; UNCLASSIFIED DRUG; ABATACEPT; ANTIBODY CONJUGATE; CD40 LIGAND; CYTOTOXIC T-LYMPHOCYTE ANTIGEN 4; DIFFERENTIATION ANTIGEN; GALACTOSYLTRANSFERASE; LEUKOCYTE ANTIGEN;

ALLOTRANSPLANTATION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY RESPONSE; ARTICLE; CONTROLLED STUDY; DRUG MECHANISM; GRAFT REJECTION; GRAFT SURVIVAL; HEART TRANSPLANTATION; HISTOPATHOLOGY; HUMORAL IMMUNITY; KNOCKOUT MOUSE; MONOTHERAPY; MOUSE; NONHUMAN; RAT; TREATMENT OUTCOME; XENOGRAFT; XENOTRANSPLANTATION; ANIMAL; ANTIBODY PRODUCTION; GENETICS; IMMUNOLOGY; LEWIS RAT; METABOLISM; MOUSE MUTANT;

ANIMALS; ANTIBODY FORMATION; ANTIGENS, CD; ANTIGENS, DIFFERENTIATION; CD40 LIGAND; GALACTOSYLTRANSFERASES; GRAFT SURVIVAL; HEART TRANSPLANTATION; IMMUNOCONJUGATES; MICE; MICE, KNOCKOUT; RATS; RATS, INBRED LEW; TRANSPLANTATION, HETEROLOGOUS;

EID: 0035985310     PISSN: 16006135     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-6143.2002.020108.x     Document Type: Article

References (32)

1. Kenyon NS, Chatzipetrou M, Masetti M et al. Long-term survival and function of intrahepatic islet allografts in rhesus monkeys treated with humanized anti-CD154. Proc Natl Acad Sci USA 1999; 96: 8132-8137.
2. Kenyon NS, Fernandez LA, Lehmann R et al. Long-term survival and function of intrahepatic islet allografts in baboons treated with humanized anti-CD154. Diabetes 1999; 48: 1473-1481.
3. Kirk AD, Burkly LC, Batty DS et al. Treatment with humanized monoclonal antibody against CD154 prevents acute renal allograft rejection in nonhuman primates [see comments]. Nat Med 1999; 5: 686-693.
4. Kirk AD, Harlan DM, Armstrong NN et al. CTLA4-lg and anti-CD40 ligand prevent renal allograft rejection in primates. Proc Natl Acad Sci USA 1997; 94: 8789-8794.
5. Larsen CP, Elwood ET, Alexander DZ et al. Long-term acceptance of skin and cardiac allografts after blocking CD40 and CD28 pathways. Nature 1996; 381: 434-438.
6. Rehman A, Tu Y, Arima T, Linsley PS, Flye MW. Long-term survival of rat to mouse cardiac xenografts with prolonged blockade of CD28-B7 interaction combined with peritransplant T-cell depletion. Surgery 1996; 120: 205-212.
7. Trambley J, Bingaman AW, Lin A et al. Asialo GM1 (+) CD8 (+) T cells play a critical role in costimulation blockade-resistant allograft rejection. J Clin Invest 1999; 104: 1715-1722.
8. Li Y, Zheng XX, Li XC, Zand MS, Strom TB. Combined costimulation blockade plus rapamycin but not cyclosporine produces permanent engraftment. Transplantation 1998; 66: 1387-1388.
9. Markees TG, Phillips NE, Noelle RJ et al. Prolonged survival of mouse skin allografts in recipients treated with donor splenocytes and antibody to CD40 ligand. Transplantation 1997; 64: 329-335.
10. Williams MA, Trambley J, Ha J et al. Genetic Characterization of strain differences in the ability to mediate CD40/CD28-independent rejection of skin allografts. J Immunol 2001; 165: 6849-6857.
11. Newell KA, He G, Guo Z et al. Cutting edge. blockade of the CD28/B7 costimulatory pathway inhibits intestinal allograft rejection mediated by CD4+ but not CD8+ T cells. J Immunol 1999; 163: 2358-2362.
12. Kishimoto K, Dong VM, Issazadeh S et al. The role of CD154-CD40 versus CD28-B7 costimulatory pathways in regulating allogeneic Th1 and Th2 responses in vivo. J Clin Invest 2000; 106: 63-72.
13. Hancock WW, Sayegh MH, Zheng XG, Peach R, Linsley PS, Turka LA. Costimulatory function and expression of CD40 ligand, CD80, and CD86 in vascularized murine cardiac allograft rejection. Proc Natl Acad Sci USA 1996; 93: 13967-13972.
14. Iwakoshi NN, Mordes JP, Markees TG, Phillips NE, Rossini AA, Greiner DL. Treatment of allograft recipients with donor-specific transfusion and anti-CD154 antibody leads to deletion of alloreactive CD8+ T cells and prolonged graft survival in a CTLA4-dependent manner. J Immunol 2000; 164: 512-521.
15. Lehnert AM, Yi S, Burgess JS, O'Connell PJ. Pancreatic islet xenograft tolerance after short-term costimulation blockade is associated with increased CD4+ T cell apoptosis but not immune deviation. Transplantation 2000; 69: 1176-1185.
16. Lenschow DJ, Zeng Y, Thistlethwaite JR et al. Long-term survival of xenogeneic pancreatic islet grafts induced by CTLA4lg. Science 1992; 257:789-792.
17. Elwood ET, Larsen CP, Cho HR et al. Prolonged acceptance of concordant and discordant xenografts with combined CD40 and CD28 pathway blockade. Transplantation 1998; 65: 1422-1428.
18. Good A, Cooper D, Malcolm A et al. Identification of carbohydrate structures that bind human antiporcine antibodies: implication for discordant xenografting in humans. Transpl Proc 1992; 42: 559.
19. Galili U. Interaction of the natural anti-Gal antibody with alpha-galactosyl epitopes: a major obstacle for xenotransplantation in humans [see comments]. Immunol Today 1993; 14: 480-482.
20. Lin SS, Hanaway MJ, Gonzalez-Stawinski GV et al. The role of anti-Gal 1α1-3Gal antibodies in acute vascular rejection and accommodation of xenografts. Transplantion 2000; 70: 1667-1674.
21. Lin SS, Kooyman DL, Daniels LJ et al. The role of natural anti-Gal alpha 1-3Gal antibodies in hyperacute rejection of pig-to-baboon cardiac xenotransplants. Transpl Immunol 1997; 5: 212-218.
22. YuP, Parker W, Everett M, Fox I, Platt J. Immunochemical properties of anti-Gal alpha 1, 3Gal antibodies after sensitization with xenogeneic tissues. J Clin Immunol 1999; 19: 116-126.
23. Buhler L, Awwad M, Basker M et al. High-dose porcine hematopoietic cell transplantation combined with CD40 ligand blockade in baboons prevents an induced anti-pig humoral response. Transplantation 2000;69:2296-2304.
24. Chong AS-F, Ma L, Yin D et al. Non-depleting anti-CD4, but not anti-CD8, antibody induces long-term survival of xenogeneic and allogeneic hearts in α1,3-galactosyl-transferase knock-out (GT-Ko mice). Xenotransplantation 2000; 7: 275-283.
25. Ohdan H, Yang YG, Swenson KG, Thall AD, Sykes M. In vivo T-cell depletion enhances production of anti-GALalpha1,3GAL natural antibodies in alpha 1,3-galactosyltransferase- deficient mice. Transplantation 2000; 69: 910-913.
26. Thall A, Maly P, Lowe J. Oocyte Galα1, 3Gal epitopes implicated in sperm adhesion to the zona pellucida glycoprotein ZP3 are not required for fertilization in the mouse. J Biol Chem 1995; 270: 21437-21440.
27. Thall A, Murphy H, Lowe J. a1,3-galactosyltransferase-deficient mice produce naturally occurring cytotoxic anti-gal antibodies. Transpl Proc 1996; 28: 556-557.
28. Yin D, Ma L, Blinder L et al. Induction of species-specific host accommodation in the hamster-to-rat xenotransplantation model. J Immunol 1998; 161: 2044-2051.
29. Tanemura M, Yin D, Chong AS, Galili U. Differential immune responses to alpha-gal epitopes on xenografts and allografts: implications for accommodation in xenotransplantation. J Clin Invest 2000; 105: 301-310.
30. Ohdan H, Swenson KG, Kruger Gray HS et al. Mac-1-negative B-1b phenotype of natural antibody-producing cells, including those responding to Gal alpha 1, 3Gal epitopes in alpha 1, 3-galactosyl-transferase-deficient mice. J Immunol 2000: 165: 5518-5529.
31. Bach F, Ferran C, Hechenleitner P et al. Accommodation of vascularized xenografts: Expression of 'protective genes' by donor endothelial cells in a host Th2 cytokine environment. Nat Med 1997; 3: 196-204.
32. Lin Y, Vandeputte M, Waer M. Accommodation and T-independent B cell tolerance in rats with long term surviving hamster heart xenografts. J Immunol 1998; 160: 369-375.